3Dixon RM. NMR studies of phospholipid metabolism in hepatic lymphoma [J]. NMR Biomed, 1998; 11(7): 370
4Griffiths JR, Cady E, Edwards RH, et al. 31P-NMR studies of a human tumour in situ [J]. Lancet, 1983; 1(8339): 1435
5Wendland MF, Iyer SB, Fu KK, et al. Correlations between in vivo 31P MRS measurements, tumor size, cell survival, and hypoxic fraction in the murine EMT6 tumor [J]. Magn Reson Med, 1992; 25(2): 217
6Menon DK, Sargentoni J, Taylor-Robinson SD, et al. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances [J]. Hepatology, 1995; 21(2): 417
7Jalan R, Sargentoni J, Coutts GA, et al. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models [J]. Gut, 1996; 39(1): 14
8Chu WC, Lam WW, Lee KH, et al. Phosphorus-31 MR spectroscopy in pediatric liver transplant recipients: a noninvasive assessment of graft status with correlation with liver function tests and liver biopsy [J]. AJR Am J Roentgenol, 2005; 184(5): 1624
9Noren B, Lundberg P, Ressner M, et al. Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease [J]. Eur Radiol, 2005; 15(1): 148
10Taylor-Robinson SD, Sargentoni J, Bell JD, et al. In vivo and in vivo hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts [J]. Gut, 1998; 42(5): 735
